Skip to main content
. 2014 Jan 8;306(4):F457–F467. doi: 10.1152/ajprenal.00339.2013

Table 2.

Biochemical parameters in the terminal blood sample

n PNa, mM PK, mM POsm, mOsm Hematocrit, %
HCTZ time course (clearance protocol A)
    Vehicle control 5 146.6 ± 2.6 4.1 ± 0.4 303.8 ± 3.8 37.4 ± 1.7
    HCTZ (2 mg/kg) 9 143.1 ± 2.8 4.1 ± 0.2 296.8 ± 5.6 40.3 ± 2.6
HCTZ dose-range (clearance protocol C)
    Vehicle control 9 146.4 ± 1.3 4.5 ± 0.6 304.0 ± 4.0 40.4 ± 1.2
    HCTZ (0.2 mg/kg) 4 145.8 ± 1.7 4.8 ± 0.6 306.3 ± 8.0 38.5 ± 4.7
    HCTZ (2 mg/kg) 9 143.1 ± 2.8 * 4.1 ± 0.2 296.8 ± 5.6 40.3 ± 2.6
    HCTZ (20 mg/kg) 8 143.6 ± 1.8 3.9 ± 0.3 296.9 ± 4.9 44.2 ± 1.3 *
HCTZ and BZM (clearance protocol D)
    BZM plus vehicle control 6 142.2 ± 2.2 5.8 ± 0.2 306.0 ± 3.0 38.3 ± 3.2
    BZM plus HCTZ 6 139.7 ± 3.9 5.5 ± 0.4 301.5 ± 5.8 43.2 ± 2.5 *

Data are means ± 95% confidence intervals; n, no. of animals/group. PNa, concentration of Na+ in the plasma; PK, concentration of K+ in the plasma; POsm, plasma osmolality.

*

P < 0.05 for significant difference from the control group within each experiment by an unpaired t-test (clearance protocols A and D) or by a post hoc Dunnett's test after one-way ANOVA (clearance protocol C).